The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCap-xx Regulatory News (CPX)

Share Price Information for Cap-xx (CPX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0825
Bid: 0.08
Ask: 0.085
Change: 0.005 (6.45%)
Spread: 0.005 (6.25%)
Open: 0.0775
High: 0.0825
Low: 0.0775
Prev. Close: 0.0775
CPX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update re. R&D rebate and other matters

1 Dec 2023 07:00

RNS Number : 2977V
CAP-XX Limited
01 December 2023
 

1 December 2023

CAP-XX Limited

("CAP-XX" or the "Company")

Update on FY23 R&D rebate, JV with Ionic Industries and Distribution Strategy

CAP-XX Limited, a world leader in the design and manufacture of supercapacitors and energy management systems, is pleased to announce that the Australian Taxation Office has approved the FY23 research & development grant and associated rebate totaling A$2.1m. The net proceeds of A$1.0m, after repaying the principal and interest associated with the revolving line of credit drawdown, were received by CAP-XX earlier this week.

Further to the Company's announcement on 4 May 2022, CAP-XX announces that it has formally signed a joint venture ("JV") vehicle and shareholders agreement (the "Agreement") with Ionic Industries Limited ("Ionic") for the exclusive commercialisation of Ionic's reduced graphene oxide technology to increase electrode density in supercapacitors. The final terms of this Agreement are consistent with the original term sheet of the JV. Both parties are keen to make this JV a success, and a further announcement will be made once final performance evaluations and business plans for the JV have been completed and agreed.

In addition, CAP-XX is pleased to announce that the repositioning of its distribution strategy, that has been communicated over the past six months, continues to progress, with the appointment of a further European distributor, in addition to one in India and two in South Africa. New sales and application opportunities have already been identified by these distributors and purchase orders are anticipated to be received in the coming weeks. The Company is also in the final stages of negotiation with additional distributors and sales representatives and these appointments will be announced once the terms are agreed.

 

For further information contact:

 

CAP-XX Limited

Pat Elliott (Chairman) +61 (2) 9157 0000

Lars Stegmann (Chief Executive Officer)

 

Allenby Capital (Nominated Adviser and Joint Broker)

David Hart / Piers Shimwell (Corporate Finance) +44 (0) 20 3328 5656

Tony Quirke / Stefano Aquilino (Sales and Corporate Broking)

 

Cavendish Securities plc (Joint Broker)

Neil McDonald / Pearl Kellie +44 (0) 13 1220 6939

 

Kreab (Financial PR)

Robert Speed +44 (0) 20 7074 1800

 

 

More information is available at www.cap-xx.com

 

About CAP-XX

CAP-XX (LSE:CPX) is a world leader in the design and manufacture of ultra-thin prismatic and compact cylindrical supercapacitors. Its prismatic supercapacitors are manufactured in Australia and Malaysia and its cylindrical supercapacitors are manufactured in China. The company's strong intellectual property (IP) portfolio includes 11 patent families. CAP-XX's ultra-thin prismatic supercapacitors are ideal for space-constrained electronics applications where small energy storage device size and thickness are important. The unique feature of CAP-XX supercapacitors is their very high-power density and high-energy storage capacity in space-efficient thin prismatic and compact cylindrical packages. For more information, visit https://www.cap-xx.com/ or email sales@cap-xx.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFLTLLLIVIV
Date   Source Headline
22nd Dec 202011:00 amRNSPrice Monitoring Extension
22nd Dec 20207:00 amRNSProduct shipped from new production lines
18th Dec 20207:00 amRNSHolding(s) in Company
10th Dec 20208:02 amRNSExercise of employee share options
30th Nov 20207:00 amRNSHolding(s) in Company
25th Nov 20208:15 amRNSResult of AGM and Chairman’s AGM statement
3rd Nov 202012:49 pmRNSReplacement: Audited results
3rd Nov 20207:00 amRNSAudited results for the year ended 30 June 2020
23rd Oct 20207:00 amRNSNotice of Results
8th Oct 20207:00 amRNSAward of LSE Green Economy Mark
10th Sep 20207:11 amRNSCorporate update
26th Aug 20208:23 amRNSHolding(s) in Company
25th Aug 202010:21 amRNSIssue of Shares
21st Aug 20204:41 pmRNSSecond Price Monitoring Extn
21st Aug 20204:36 pmRNSPrice Monitoring Extension
21st Aug 202011:05 amRNSSecond Price Monitoring Extn
21st Aug 202011:00 amRNSPrice Monitoring Extension
17th Aug 20207:35 amRNSHolding(s) in Company
7th Aug 20203:18 pmRNSIoxus intellectual property judgement
26th Jun 20207:28 amRNSIssue of Shares and Director/PDMR Shareholdings
24th Jun 20208:57 amRNSChange of Auditor
19th May 20207:00 amRNSTrading Update
29th Apr 20202:06 pmRNSSecond Price Monitoring Extn
29th Apr 20202:01 pmRNSPrice Monitoring Extension
16th Mar 20207:00 amRNSInterim Results
4th Mar 20207:00 amRNSNotification of date of interim results and update
7th Jan 20207:00 amRNSHolding(s) in Company
6th Jan 20208:22 amRNSHolding(s) in Company
30th Dec 20198:30 amRNSResult of General Meeting
24th Dec 20197:00 amRNSResult of Offer to Qualifying Participants
29th Nov 20199:57 amRNSReplacement: Proposed Acquisition and Fundraising
29th Nov 20197:00 amRNSProposed Acquisition from Murata and Fundraising
28th Nov 20198:53 amRNSResult of AGM
13th Nov 20197:00 amRNSNotice of AGM
8th Nov 20197:00 amRNSAudited results for the year ended 30 June 2019
11th Sep 20197:00 amRNSHolding(s) in Company
31st Jul 20198:48 amRNSHolding(s) in Company
2nd Jul 20197:00 amRNSUS court action settlement and licence agreement
25th Jun 201910:45 amRNSIssue of Shares and Director/PDMR Shareholdings
7th Jun 20198:59 amRNSHolding(s) in Company
6th Jun 20199:03 amRNSTrading Update
30th May 20198:27 amRNSHolding(s) in Company
17th Apr 20193:09 pmRNSHolding(s) in Company
16th Apr 20197:00 amRNSTrading Update
6th Mar 20197:00 amRNSInterim Results
1st Mar 20197:36 amRNSDirector Disclosure Update
22nd Jan 20198:32 amRNSHolding(s) in Company
20th Dec 20188:43 amRNSIssue of Shares and Director/PDMR Shareholdings
20th Nov 20188:29 amRNSResult of AGM and Chairman's AGM statement
14th Nov 20187:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.